Cidara Therapeutics (CDTX) Short Interest Ratio & Short Volume

Short interest is the volume of Cidara Therapeutics shares that have been sold short but have not yet been covered or closed out. As of March 31st, traders have sold 195,400 shares of CDTX short. Learn More on Cidara Therapeutics' current short interest.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Cidara Therapeutics: Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Cidara Therapeutics saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 195,400 shares, an increase of 8.9% from the previous total of 179,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the sector of "medical" compare to Cidara Therapeutics: Entera Bio Ltd. (0.31%), Instil Bio, Inc. (0.22%), Turnstone Biologics Corp. (4.74%), Aligos Therapeutics, Inc. (1.15%), Elutia Inc. (0.14%), Genenta Science S.p.A. (0.02%), Ikena Oncology, Inc. (4.97%), Semper Paratus Acquisition Co. (0.25%), Cognition Therapeutics, Inc. (0.53%), Gritstone bio, Inc. (9.40%),

As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks.

Short selling CDTX is an investing strategy that aims to generate trading profit from Cidara Therapeutics as its price is falling. CDTX shares are trading down $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Cidara Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CDTX, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CDTX, twice per month. The most recent reporting period available is March, 31 2024.